|
⚲
|
| Keyboard |
| OVID Therapeutics Inc | |
|---|---|
| Ticker | OVID |
| CIK # | 0001636651 |
| CUSIP | 690469101 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1460 Broadway Suite 15044, New York, NY 10036 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| OVID Therapeutics Inc | 2017-01-20 | 25.9 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001636651] | 10-K | |
| [0001636651] | 10-Q | |
| [0001636651] | 3 | |
| [0001636651] | 4 | |
| [0001636651] | 8-K | |
| [0001636651] | D | |
| [0001636651] | SC 13D | |
| [0001636651] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Levin Jeremy M
Series A Warrant (right to buy) · derivative
|
2026-03-23 | Option exercise | 47,333 | $0.00 | |
|
Levin Jeremy M
Common Stock
|
2026-03-23 | Option exercise | 47,333 | $1.40 | 66,266 |
|
Papadopoulos Stelios
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 65,000 | $0.00 | |
|
Levin Jeremy M
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 957,000 | $0.00 | |
|
Fitzgerald Kevin Joseph
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 65,000 | $0.00 | |
|
Friedman Bart
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 65,000 | $0.00 | |
|
Duncan Barbara Gayle
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 65,000 | $0.00 | |
|
Bernstein Karen
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 65,000 | $0.00 | |
|
Alexander Margaret A
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 1,435,000 | $0.00 | |
|
Rona Jeffrey A
Employee Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 408,750 | $0.00 | |
|
Rona Jeffrey A
Common Stock
|
2026-02-26 | Grant | 68,125 | $0.00 | |
|
Rona Jeffrey A
Common Stock
|
2026-02-23 | Sell | 8,541 | $1.45 | 12,384 |
|
Alexander Margaret A
Common Stock
|
2026-02-23 | Sell | 11,656 | $1.45 | 16,901 |
|
Alexander Margaret A
Employee Stock Option (right to buy) · derivative
|
2026-01-04 | Grant | 890,000 | $0.00 | |
|
Levin Jeremy M
Series B Convertible Preferred Stock · derivative
|
2025-12-15 | Conversion | 71 | $0.00 | |
|
Levin Jeremy M
Common Stock
|
2025-12-15 | Conversion | 71,000 | ||
|
Levin Jeremy M
Series B Convertible Preferred Stock · derivative
|
2025-12-11 | Buy | 71 | ||
|
Levin Jeremy M
Series A Warrant (right to buy) · derivative
|
2025-12-11 | Buy | 47,333 | ||
|
Levin Jeremy M
Series B Warrant (right to buy) · derivative
|
2025-12-11 | Buy | 35,500 | ||
|
Takeda Pharmaceuticals USA Inc +1
Series A Convertible Preferred Stock · derivative
|
2025-12-08 | Conversion | 1,250 | $0.00 | |
| showing 20 of 184 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 103 | 105,337,678 |
| 2025-12-31 | 84 | 60,692,224 |
| 2025-09-30 | 81 | 33,727,230 |
| 2025-06-30 | 72 | 35,307,427 |
| 2025-03-31 | 83 | 45,723,622 |
| 2024-12-31 | 83 | 46,890,597 |
| 2024-09-30 | 77 | 45,212,140 |
| 2024-06-30 | 77 | 46,377,874 |
| 2024-03-31 | 82 | 49,051,082 |
| 2023-12-31 | 78 | 50,454,179 |
| 2023-09-30 | 65 | 39,325,777 |
| 2023-06-30 | 70 | 37,919,939 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Benin Management Corp | [2026-06-30] | SOLE | 0 | 19,000 |
| Assenagon Asset Management SA | [2026-06-30] | SOLE | 17,544 | 17,544 |
| Aaron Wealth Advisors LLC | [2026-06-30] | SOLE | 11,234 | 11,234 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 312 | 312 | Prev | Page 1 | Next |